You are here

TGA Internet site archive

The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.

TGA business plan 2014-2015

Therapeutic Goods Administration

25 November 2014

Book pagination


The table below summarises the risks faced by TGA that are rated as high:

Risk name Risk treatment Strategic risk theme New or emerging risk?
A product is released onto the Australian market which poses an unacceptable level of risk.
  1. TGA Offices to maintain environmental scans to ensure that risks from emerging technologies are mitigated
  2. Expand external evaluation panel to ensure that expertise is available
Delivery1 Existing risk
Public access to therapeutic products is restricted or delayed.
  1. Expand external evaluation panel to ensure that expertise is available
  2. Identify critical job roles and implement succession planning to ensure corporate knowledge is retained
  3. Implement therapeutic goods reforms as identified in the 2014-2015 TGA Business Plan
Stakeholder2 Existing risk

image of a stocked medical cabinet

  1. Department fails to meet expectations for delivery of medium to long term health policy reform agenda
  2. Effective engagement with other government agencies is not maintained and/or engagement with other external stakeholders is not effective.

Book pagination